More intensive studies are needed in larger populations to better characterize the impact of polymorphisms of SLC2A2, SLC2A5, and KHK on the development of adverse metabolic effects and increased disease risks, especially since recent studies have linked SNPs of SLC2A2 to the development of type 2 diabetes. Here, SLC2A5 is linked to type 2 diabetes mellitus.